2023. Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study). SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s262. DOI:https://doi.org/10.25251/skin.7.supp.262.